nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Cytochrome P450 2C19 Inhibitors—Esomeprazole—Barrett's esophagus	0.242	1	CiPCiCtD
Omeprazole—Esomeprazole—Barrett's esophagus	0.209	1	CrCtD
Omeprazole—ATP4A—Barrett's esophagus	0.0978	1	CbGaD
Omeprazole—ATP4B—Esomeprazole—Barrett's esophagus	0.0617	0.482	CbGbCtD
Omeprazole—ATP4A—Esomeprazole—Barrett's esophagus	0.0617	0.482	CbGbCtD
Omeprazole—esophageal cancer—Esomeprazole—Barrett's esophagus	0.0585	0.441	CpDpCtD
Omeprazole—Pantoprazole—Esomeprazole—Barrett's esophagus	0.0472	0.353	CrCrCtD
Omeprazole—Rabeprazole—Esomeprazole—Barrett's esophagus	0.0472	0.353	CrCrCtD
Omeprazole—Lansoprazole—Esomeprazole—Barrett's esophagus	0.0395	0.295	CrCrCtD
Omeprazole—kidney cancer—Esomeprazole—Barrett's esophagus	0.0336	0.254	CpDpCtD
Omeprazole—prostate cancer—Esomeprazole—Barrett's esophagus	0.0243	0.183	CpDpCtD
Omeprazole—systemic scleroderma—Esomeprazole—Barrett's esophagus	0.0161	0.122	CpDpCtD
Omeprazole—ATP4A—gastric juice—Barrett's esophagus	0.005	0.642	CbGeAlD
Omeprazole—CYP2C19—Esomeprazole—Barrett's esophagus	0.00313	0.0244	CbGbCtD
Omeprazole—ATP4A—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00217	0.269	CbGpPWpGaD
Omeprazole—CYP3A4—Esomeprazole—Barrett's esophagus	0.00151	0.0118	CbGbCtD
Omeprazole—ATP4B—digestive system—Barrett's esophagus	0.0007	0.0899	CbGeAlD
Omeprazole—ATP4B—Ion transport by P-type ATPases—ATP4A—Barrett's esophagus	0.000545	0.0676	CbGpPWpGaD
Omeprazole—ATP4A—epithelium—Barrett's esophagus	0.000401	0.0515	CbGeAlD
Omeprazole—Esomeprazole—ATP4A—Barrett's esophagus	0.000358	0.335	CrCbGaD
Omeprazole—ATP4A—digestive system—Barrett's esophagus	0.000305	0.0391	CbGeAlD
Omeprazole—ABCC3—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000294	0.0364	CbGpPWpGaD
Omeprazole—Pantoprazole—ATP4A—Barrett's esophagus	0.000259	0.242	CrCbGaD
Omeprazole—Rabeprazole—ATP4A—Barrett's esophagus	0.000259	0.242	CrCbGaD
Omeprazole—CYP2C18—digestive system—Barrett's esophagus	0.00025	0.0322	CbGeAlD
Omeprazole—Lansoprazole—ATP4A—Barrett's esophagus	0.000193	0.181	CrCbGaD
Omeprazole—ATP4B—Ion channel transport—ATP4A—Barrett's esophagus	0.000189	0.0234	CbGpPWpGaD
Omeprazole—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000169	0.0209	CbGpPWpGaD
Omeprazole—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000169	0.0209	CbGpPWpGaD
Omeprazole—Allergic cutaneous angiitis—Esomeprazole—Barrett's esophagus	0.000157	0.00395	CcSEcCtD
Omeprazole—ABCC3—digestive system—Barrett's esophagus	0.000155	0.0199	CbGeAlD
Omeprazole—CYP1B1—smooth muscle tissue—Barrett's esophagus	0.000154	0.0197	CbGeAlD
Omeprazole—Tachypnoea—Esomeprazole—Barrett's esophagus	0.000146	0.00368	CcSEcCtD
Omeprazole—Pyuria—Esomeprazole—Barrett's esophagus	0.000143	0.0036	CcSEcCtD
Omeprazole—Goitre—Esomeprazole—Barrett's esophagus	0.00014	0.00352	CcSEcCtD
Omeprazole—Oesophageal ulcer—Esomeprazole—Barrett's esophagus	0.000137	0.00345	CcSEcCtD
Omeprazole—Hypochromic anaemia—Esomeprazole—Barrett's esophagus	0.000129	0.00324	CcSEcCtD
Omeprazole—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000127	0.0158	CbGpPWpGaD
Omeprazole—CYP11A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000126	0.0156	CbGpPWpGaD
Omeprazole—Retrosternal pain—Esomeprazole—Barrett's esophagus	0.000124	0.00312	CcSEcCtD
Omeprazole—CYP1B1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000124	0.0154	CbGpPWpGaD
Omeprazole—CYP1B1—digestive system—Barrett's esophagus	0.000121	0.0156	CbGeAlD
Omeprazole—Pruritus genital—Esomeprazole—Barrett's esophagus	0.00012	0.00301	CcSEcCtD
Omeprazole—Dysaesthesia—Esomeprazole—Barrett's esophagus	0.000116	0.00291	CcSEcCtD
Omeprazole—CYP1A1—epithelium—Barrett's esophagus	0.000113	0.0145	CbGeAlD
Omeprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00011	0.0137	CbGpPWpGaD
Omeprazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000109	0.0136	CbGpPWpGaD
Omeprazole—CYP2C18—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000109	0.0135	CbGpPWpGaD
Omeprazole—Leg pain—Esomeprazole—Barrett's esophagus	0.000108	0.00272	CcSEcCtD
Omeprazole—Ulcerative stomatitis—Esomeprazole—Barrett's esophagus	0.000108	0.00272	CcSEcCtD
Omeprazole—Hernia—Esomeprazole—Barrett's esophagus	0.000107	0.00268	CcSEcCtD
Omeprazole—CYP2C19—digestive system—Barrett's esophagus	0.000106	0.0137	CbGeAlD
Omeprazole—Nephrotic syndrome—Esomeprazole—Barrett's esophagus	0.000103	0.0026	CcSEcCtD
Omeprazole—Epigastric pain—Esomeprazole—Barrett's esophagus	0.000103	0.0026	CcSEcCtD
Omeprazole—Tongue discolouration—Esomeprazole—Barrett's esophagus	0.000103	0.0026	CcSEcCtD
Omeprazole—CYP11A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000103	0.0128	CbGpPWpGaD
Omeprazole—Rectal disorder—Esomeprazole—Barrett's esophagus	0.000102	0.00256	CcSEcCtD
Omeprazole—Leukocytoclastic vasculitis—Esomeprazole—Barrett's esophagus	0.000102	0.00256	CcSEcCtD
Omeprazole—Anorectal disorder—Esomeprazole—Barrett's esophagus	9.51e-05	0.00239	CcSEcCtD
Omeprazole—Anorectal discomfort—Esomeprazole—Barrett's esophagus	9.14e-05	0.0023	CcSEcCtD
Omeprazole—Urine abnormality—Esomeprazole—Barrett's esophagus	9.03e-05	0.00227	CcSEcCtD
Omeprazole—CYP2C18—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	8.93e-05	0.0111	CbGpPWpGaD
Omeprazole—Sleep disturbance—Esomeprazole—Barrett's esophagus	8.92e-05	0.00224	CcSEcCtD
Omeprazole—Tongue oedema—Esomeprazole—Barrett's esophagus	8.92e-05	0.00224	CcSEcCtD
Omeprazole—Foetor hepaticus—Esomeprazole—Barrett's esophagus	8.81e-05	0.00222	CcSEcCtD
Omeprazole—CYP1A2—digestive system—Barrett's esophagus	8.7e-05	0.0112	CbGeAlD
Omeprazole—Fracture—Esomeprazole—Barrett's esophagus	8.6e-05	0.00216	CcSEcCtD
Omeprazole—Hepatic necrosis—Esomeprazole—Barrett's esophagus	8.6e-05	0.00216	CcSEcCtD
Omeprazole—Multiple fractures—Esomeprazole—Barrett's esophagus	8.6e-05	0.00216	CcSEcCtD
Omeprazole—CYP1A1—digestive system—Barrett's esophagus	8.58e-05	0.011	CbGeAlD
Omeprazole—Urine analysis abnormal—Esomeprazole—Barrett's esophagus	8.5e-05	0.00214	CcSEcCtD
Omeprazole—Generalised oedema—Esomeprazole—Barrett's esophagus	8.4e-05	0.00211	CcSEcCtD
Omeprazole—Visual acuity reduced—Esomeprazole—Barrett's esophagus	8.4e-05	0.00211	CcSEcCtD
Omeprazole—Enlargement abdomen—Esomeprazole—Barrett's esophagus	8.31e-05	0.00209	CcSEcCtD
Omeprazole—CYP2C9—digestive system—Barrett's esophagus	8.25e-05	0.0106	CbGeAlD
Omeprazole—Polyp—Esomeprazole—Barrett's esophagus	8.22e-05	0.00207	CcSEcCtD
Omeprazole—Optic neuritis—Esomeprazole—Barrett's esophagus	8.13e-05	0.00204	CcSEcCtD
Omeprazole—Eruption—Esomeprazole—Barrett's esophagus	8.13e-05	0.00204	CcSEcCtD
Omeprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	8.12e-05	0.0101	CbGpPWpGaD
Omeprazole—ABCG2—Irinotecan Pathway—APC—Barrett's esophagus	8.07e-05	0.01	CbGpPWpGaD
Omeprazole—CYP1B1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	8.01e-05	0.00993	CbGpPWpGaD
Omeprazole—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	7.87e-05	0.00198	CcSEcCtD
Omeprazole—Encephalopathy—Esomeprazole—Barrett's esophagus	7.79e-05	0.00196	CcSEcCtD
Omeprazole—Laryngeal oedema—Esomeprazole—Barrett's esophagus	7.79e-05	0.00196	CcSEcCtD
Omeprazole—Parosmia—Esomeprazole—Barrett's esophagus	7.71e-05	0.00194	CcSEcCtD
Omeprazole—CYP1A1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	7.63e-05	0.00946	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	7.48e-05	0.00928	CbGpPWpGaD
Omeprazole—Cyst—Esomeprazole—Barrett's esophagus	7.48e-05	0.00188	CcSEcCtD
Omeprazole—Nephritis interstitial—Esomeprazole—Barrett's esophagus	7.4e-05	0.00186	CcSEcCtD
Omeprazole—Liver disorder—Esomeprazole—Barrett's esophagus	7.33e-05	0.00184	CcSEcCtD
Omeprazole—Menstrual disorder—Esomeprazole—Barrett's esophagus	7.33e-05	0.00184	CcSEcCtD
Omeprazole—Apathy—Esomeprazole—Barrett's esophagus	7e-05	0.00176	CcSEcCtD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	7e-05	0.00868	CbGpPWpGaD
Omeprazole—Flat affect—Esomeprazole—Barrett's esophagus	6.93e-05	0.00174	CcSEcCtD
Omeprazole—Tongue disorder—Esomeprazole—Barrett's esophagus	6.87e-05	0.00173	CcSEcCtD
Omeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	6.75e-05	0.00837	CbGpPWpGaD
Omeprazole—Albuminuria—Esomeprazole—Barrett's esophagus	6.69e-05	0.00168	CcSEcCtD
Omeprazole—Scotoma—Esomeprazole—Barrett's esophagus	6.58e-05	0.00166	CcSEcCtD
Omeprazole—CYP1B1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	6.58e-05	0.00816	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.56e-05	0.00814	CbGpPWpGaD
Omeprazole—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	6.53e-05	0.00164	CcSEcCtD
Omeprazole—Rash erythematous—Esomeprazole—Barrett's esophagus	6.53e-05	0.00164	CcSEcCtD
Omeprazole—Fungal infection—Esomeprazole—Barrett's esophagus	6.47e-05	0.00163	CcSEcCtD
Omeprazole—Otitis media—Esomeprazole—Barrett's esophagus	6.42e-05	0.00161	CcSEcCtD
Omeprazole—Necrosis—Esomeprazole—Barrett's esophagus	6.37e-05	0.0016	CcSEcCtD
Omeprazole—CYP3A4—digestive system—Barrett's esophagus	6.29e-05	0.00808	CbGeAlD
Omeprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	6.29e-05	0.0078	CbGpPWpGaD
Omeprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	6.29e-05	0.0078	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	6.24e-05	0.00774	CbGpPWpGaD
Omeprazole—CYP2D6—digestive system—Barrett's esophagus	6.19e-05	0.00796	CbGeAlD
Omeprazole—Glycosuria—Esomeprazole—Barrett's esophagus	6.17e-05	0.00155	CcSEcCtD
Omeprazole—Ageusia—Esomeprazole—Barrett's esophagus	6.17e-05	0.00155	CcSEcCtD
Omeprazole—Rigors—Esomeprazole—Barrett's esophagus	6.12e-05	0.00154	CcSEcCtD
Omeprazole—Petechiae—Esomeprazole—Barrett's esophagus	6.07e-05	0.00153	CcSEcCtD
Omeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	5.88e-05	0.00729	CbGpPWpGaD
Omeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	5.88e-05	0.00729	CbGpPWpGaD
Omeprazole—ABCB1—epithelium—Barrett's esophagus	5.86e-05	0.00752	CbGeAlD
Omeprazole—Eye irritation—Esomeprazole—Barrett's esophagus	5.85e-05	0.00147	CcSEcCtD
Omeprazole—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	5.73e-05	0.00711	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	5.69e-05	0.00706	CbGpPWpGaD
Omeprazole—Proteinuria—Esomeprazole—Barrett's esophagus	5.69e-05	0.00143	CcSEcCtD
Omeprazole—Aggression—Esomeprazole—Barrett's esophagus	5.69e-05	0.00143	CcSEcCtD
Omeprazole—Accidental injury—Esomeprazole—Barrett's esophagus	5.65e-05	0.00142	CcSEcCtD
Omeprazole—Protein urine present—Esomeprazole—Barrett's esophagus	5.61e-05	0.00141	CcSEcCtD
Omeprazole—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	5.55e-05	0.00688	CbGpPWpGaD
Omeprazole—Bone disorder—Esomeprazole—Barrett's esophagus	5.53e-05	0.00139	CcSEcCtD
Omeprazole—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	5.53e-05	0.00139	CcSEcCtD
Omeprazole—Dysmenorrhoea—Esomeprazole—Barrett's esophagus	5.5e-05	0.00138	CcSEcCtD
Omeprazole—Arthropathy—Esomeprazole—Barrett's esophagus	5.5e-05	0.00138	CcSEcCtD
Omeprazole—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	5.5e-05	0.00138	CcSEcCtD
Omeprazole—CYP11A1—Biological oxidations—CYP26A1—Barrett's esophagus	5.48e-05	0.0068	CbGpPWpGaD
Omeprazole—Hypocalcaemia—Esomeprazole—Barrett's esophagus	5.46e-05	0.00137	CcSEcCtD
Omeprazole—Glossitis—Esomeprazole—Barrett's esophagus	5.42e-05	0.00136	CcSEcCtD
Omeprazole—CYP11A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.4e-05	0.0067	CbGpPWpGaD
Omeprazole—Hyperuricaemia—Esomeprazole—Barrett's esophagus	5.39e-05	0.00136	CcSEcCtD
Omeprazole—Leukocytosis—Esomeprazole—Barrett's esophagus	5.32e-05	0.00134	CcSEcCtD
Omeprazole—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	5.28e-05	0.00133	CcSEcCtD
Omeprazole—Creatinine increased—Esomeprazole—Barrett's esophagus	5.25e-05	0.00132	CcSEcCtD
Omeprazole—Blood uric acid increased—Esomeprazole—Barrett's esophagus	5.09e-05	0.00128	CcSEcCtD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	5.02e-05	0.00623	CbGpPWpGaD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	5.02e-05	0.00623	CbGpPWpGaD
Omeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	5e-05	0.0062	CbGpPWpGaD
Omeprazole—Hiccups—Esomeprazole—Barrett's esophagus	5e-05	0.00126	CcSEcCtD
Omeprazole—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	5e-05	0.00126	CcSEcCtD
Omeprazole—Hepatocellular injury—Esomeprazole—Barrett's esophagus	5e-05	0.00126	CcSEcCtD
Omeprazole—Blood pressure increased—Esomeprazole—Barrett's esophagus	5e-05	0.00126	CcSEcCtD
Omeprazole—Vaginal inflammation—Esomeprazole—Barrett's esophagus	5e-05	0.00126	CcSEcCtD
Omeprazole—Injection site reaction—Esomeprazole—Barrett's esophagus	4.97e-05	0.00125	CcSEcCtD
Omeprazole—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	4.93e-05	0.00612	CbGpPWpGaD
Omeprazole—Eructation—Esomeprazole—Barrett's esophagus	4.91e-05	0.00124	CcSEcCtD
Omeprazole—Cystitis noninfective—Esomeprazole—Barrett's esophagus	4.88e-05	0.00123	CcSEcCtD
Omeprazole—Melaena—Esomeprazole—Barrett's esophagus	4.88e-05	0.00123	CcSEcCtD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	4.87e-05	0.00603	CbGpPWpGaD
Omeprazole—Cystitis—Esomeprazole—Barrett's esophagus	4.83e-05	0.00121	CcSEcCtD
Omeprazole—Candida infection—Esomeprazole—Barrett's esophagus	4.77e-05	0.0012	CcSEcCtD
Omeprazole—Fluid retention—Esomeprazole—Barrett's esophagus	4.74e-05	0.00119	CcSEcCtD
Omeprazole—CYP2C18—Biological oxidations—CYP26A1—Barrett's esophagus	4.74e-05	0.00588	CbGpPWpGaD
Omeprazole—Vaginal infection—Esomeprazole—Barrett's esophagus	4.72e-05	0.00119	CcSEcCtD
Omeprazole—CYP2C18—Metapathway biotransformation—CYP26A1—Barrett's esophagus	4.68e-05	0.0058	CbGpPWpGaD
Omeprazole—Dry eye—Esomeprazole—Barrett's esophagus	4.62e-05	0.00116	CcSEcCtD
Omeprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	4.58e-05	0.00568	CbGpPWpGaD
Omeprazole—Oesophagitis—Esomeprazole—Barrett's esophagus	4.57e-05	0.00115	CcSEcCtD
Omeprazole—Rash maculo-papular—Esomeprazole—Barrett's esophagus	4.54e-05	0.00114	CcSEcCtD
Omeprazole—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	4.52e-05	0.00561	CbGpPWpGaD
Omeprazole—Neoplasm—Esomeprazole—Barrett's esophagus	4.52e-05	0.00114	CcSEcCtD
Omeprazole—Mouth ulceration—Esomeprazole—Barrett's esophagus	4.52e-05	0.00114	CcSEcCtD
Omeprazole—Urine output increased—Esomeprazole—Barrett's esophagus	4.52e-05	0.00114	CcSEcCtD
Omeprazole—Bladder pain—Esomeprazole—Barrett's esophagus	4.52e-05	0.00114	CcSEcCtD
Omeprazole—Gynaecomastia—Esomeprazole—Barrett's esophagus	4.47e-05	0.00112	CcSEcCtD
Omeprazole—Lightheadedness—Esomeprazole—Barrett's esophagus	4.47e-05	0.00112	CcSEcCtD
Omeprazole—ABCB1—digestive system—Barrett's esophagus	4.46e-05	0.00572	CbGeAlD
Omeprazole—Hypertonia—Esomeprazole—Barrett's esophagus	4.38e-05	0.0011	CcSEcCtD
Omeprazole—Abnormal vision—Esomeprazole—Barrett's esophagus	4.36e-05	0.0011	CcSEcCtD
Omeprazole—Ear pain—Esomeprazole—Barrett's esophagus	4.25e-05	0.00107	CcSEcCtD
Omeprazole—Lymphadenopathy—Esomeprazole—Barrett's esophagus	4.25e-05	0.00107	CcSEcCtD
Omeprazole—Sleep disorder—Esomeprazole—Barrett's esophagus	4.19e-05	0.00105	CcSEcCtD
Omeprazole—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	4.17e-05	0.00105	CcSEcCtD
Omeprazole—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	4.15e-05	0.00104	CcSEcCtD
Omeprazole—Polyuria—Esomeprazole—Barrett's esophagus	4.13e-05	0.00104	CcSEcCtD
Omeprazole—Photosensitivity—Esomeprazole—Barrett's esophagus	4.13e-05	0.00104	CcSEcCtD
Omeprazole—Swelling—Esomeprazole—Barrett's esophagus	4.11e-05	0.00103	CcSEcCtD
Omeprazole—Gastroenteritis—Esomeprazole—Barrett's esophagus	4.09e-05	0.00103	CcSEcCtD
Omeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	4.09e-05	0.00507	CbGpPWpGaD
Omeprazole—Vascular purpura—Esomeprazole—Barrett's esophagus	4.06e-05	0.00102	CcSEcCtD
Omeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	4.05e-05	0.00503	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	4.04e-05	0.00502	CbGpPWpGaD
Omeprazole—Hepatic failure—Esomeprazole—Barrett's esophagus	4.04e-05	0.00102	CcSEcCtD
Omeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	4.04e-05	0.00501	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.02e-05	0.00499	CbGpPWpGaD
Omeprazole—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	4.02e-05	0.00101	CcSEcCtD
Omeprazole—Injury—Esomeprazole—Barrett's esophagus	3.95e-05	0.000993	CcSEcCtD
Omeprazole—Hot flush—Esomeprazole—Barrett's esophagus	3.88e-05	0.000976	CcSEcCtD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	3.87e-05	0.00481	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	3.87e-05	0.00481	CbGpPWpGaD
Omeprazole—Increased appetite—Esomeprazole—Barrett's esophagus	3.86e-05	0.000971	CcSEcCtD
Omeprazole—Menopausal symptoms—Esomeprazole—Barrett's esophagus	3.84e-05	0.000967	CcSEcCtD
Omeprazole—Visual disturbance—Esomeprazole—Barrett's esophagus	3.83e-05	0.000963	CcSEcCtD
Omeprazole—Thirst—Esomeprazole—Barrett's esophagus	3.81e-05	0.000959	CcSEcCtD
Omeprazole—Renal impairment—Esomeprazole—Barrett's esophagus	3.81e-05	0.000959	CcSEcCtD
Omeprazole—Purpura—Esomeprazole—Barrett's esophagus	3.76e-05	0.000947	CcSEcCtD
Omeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	3.76e-05	0.00467	CbGpPWpGaD
Omeprazole—Arthritis—Esomeprazole—Barrett's esophagus	3.73e-05	0.000939	CcSEcCtD
Omeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	3.73e-05	0.00463	CbGpPWpGaD
Omeprazole—Hypoglycaemia—Esomeprazole—Barrett's esophagus	3.72e-05	0.000935	CcSEcCtD
Omeprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	3.72e-05	0.00461	CbGpPWpGaD
Omeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	3.71e-05	0.0046	CbGpPWpGaD
Omeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	3.68e-05	0.00456	CbGpPWpGaD
Omeprazole—Hyponatraemia—Esomeprazole—Barrett's esophagus	3.64e-05	0.000916	CcSEcCtD
Omeprazole—Pain in extremity—Esomeprazole—Barrett's esophagus	3.63e-05	0.000913	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	3.63e-05	0.000913	CcSEcCtD
Omeprazole—Diplopia—Esomeprazole—Barrett's esophagus	3.63e-05	0.000913	CcSEcCtD
Omeprazole—Osteoarthritis—Esomeprazole—Barrett's esophagus	3.63e-05	0.000913	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.59e-05	0.00445	CbGpPWpGaD
Omeprazole—Migraine—Esomeprazole—Barrett's esophagus	3.57e-05	0.000898	CcSEcCtD
Omeprazole—Face oedema—Esomeprazole—Barrett's esophagus	3.5e-05	0.000881	CcSEcCtD
Omeprazole—CYP1B1—Biological oxidations—CYP26A1—Barrett's esophagus	3.5e-05	0.00433	CbGpPWpGaD
Omeprazole—Irritability—Esomeprazole—Barrett's esophagus	3.46e-05	0.000871	CcSEcCtD
Omeprazole—CYP1B1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	3.45e-05	0.00428	CbGpPWpGaD
Omeprazole—Blood creatinine increased—Esomeprazole—Barrett's esophagus	3.4e-05	0.000855	CcSEcCtD
Omeprazole—Dry skin—Esomeprazole—Barrett's esophagus	3.33e-05	0.000837	CcSEcCtD
Omeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	3.32e-05	0.00411	CbGpPWpGaD
Omeprazole—Abdominal pain upper—Esomeprazole—Barrett's esophagus	3.31e-05	0.000834	CcSEcCtD
Omeprazole—Hypokalaemia—Esomeprazole—Barrett's esophagus	3.3e-05	0.000831	CcSEcCtD
Omeprazole—Breast disorder—Esomeprazole—Barrett's esophagus	3.28e-05	0.000825	CcSEcCtD
Omeprazole—Cramp muscle—Esomeprazole—Barrett's esophagus	3.27e-05	0.000822	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	3.27e-05	0.000822	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	3.27e-05	0.000822	CcSEcCtD
Omeprazole—Gastritis—Esomeprazole—Barrett's esophagus	3.21e-05	0.000808	CcSEcCtD
Omeprazole—Muscular weakness—Esomeprazole—Barrett's esophagus	3.2e-05	0.000805	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	3.2e-05	0.000805	CcSEcCtD
Omeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	3.19e-05	0.00395	CbGpPWpGaD
Omeprazole—Abdominal distension—Esomeprazole—Barrett's esophagus	3.16e-05	0.000794	CcSEcCtD
Omeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	3.15e-05	0.0039	CbGpPWpGaD
Omeprazole—Asthma—Esomeprazole—Barrett's esophagus	3.14e-05	0.000789	CcSEcCtD
Omeprazole—Influenza—Esomeprazole—Barrett's esophagus	3.14e-05	0.000789	CcSEcCtD
Omeprazole—Dysphagia—Esomeprazole—Barrett's esophagus	3.14e-05	0.000789	CcSEcCtD
Omeprazole—Bronchospasm—Esomeprazole—Barrett's esophagus	3.08e-05	0.000776	CcSEcCtD
Omeprazole—Pancreatitis—Esomeprazole—Barrett's esophagus	3.07e-05	0.000773	CcSEcCtD
Omeprazole—Angina pectoris—Esomeprazole—Barrett's esophagus	3.05e-05	0.000768	CcSEcCtD
Omeprazole—Sweating increased—Esomeprazole—Barrett's esophagus	3.05e-05	0.000768	CcSEcCtD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	3.05e-05	0.00378	CbGpPWpGaD
Omeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	3.02e-05	0.00375	CbGpPWpGaD
Omeprazole—Pancytopenia—Esomeprazole—Barrett's esophagus	2.98e-05	0.000749	CcSEcCtD
Omeprazole—Dysuria—Esomeprazole—Barrett's esophagus	2.93e-05	0.000738	CcSEcCtD
Omeprazole—Neutropenia—Esomeprazole—Barrett's esophagus	2.93e-05	0.000738	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	2.91e-05	0.000733	CcSEcCtD
Omeprazole—Pollakiuria—Esomeprazole—Barrett's esophagus	2.9e-05	0.000729	CcSEcCtD
Omeprazole—Erectile dysfunction—Esomeprazole—Barrett's esophagus	2.89e-05	0.000726	CcSEcCtD
Omeprazole—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	2.86e-05	0.00072	CcSEcCtD
Omeprazole—Weight increased—Esomeprazole—Barrett's esophagus	2.85e-05	0.000718	CcSEcCtD
Omeprazole—Weight decreased—Esomeprazole—Barrett's esophagus	2.84e-05	0.000714	CcSEcCtD
Omeprazole—Infestation—Esomeprazole—Barrett's esophagus	2.8e-05	0.000703	CcSEcCtD
Omeprazole—Infestation NOS—Esomeprazole—Barrett's esophagus	2.8e-05	0.000703	CcSEcCtD
Omeprazole—Depression—Esomeprazole—Barrett's esophagus	2.79e-05	0.000701	CcSEcCtD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.78e-05	0.00344	CbGpPWpGaD
Omeprazole—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	2.77e-05	0.000697	CcSEcCtD
Omeprazole—Renal failure—Esomeprazole—Barrett's esophagus	2.75e-05	0.000691	CcSEcCtD
Omeprazole—Jaundice—Esomeprazole—Barrett's esophagus	2.73e-05	0.000686	CcSEcCtD
Omeprazole—Stomatitis—Esomeprazole—Barrett's esophagus	2.73e-05	0.000686	CcSEcCtD
Omeprazole—Conjunctivitis—Esomeprazole—Barrett's esophagus	2.72e-05	0.000684	CcSEcCtD
Omeprazole—Urinary tract infection—Esomeprazole—Barrett's esophagus	2.72e-05	0.000684	CcSEcCtD
Omeprazole—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	2.69e-05	0.00333	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	2.67e-05	0.00332	CbGpPWpGaD
Omeprazole—Haematuria—Esomeprazole—Barrett's esophagus	2.67e-05	0.000671	CcSEcCtD
Omeprazole—ABCC3—Fluoropyrimidine Activity—TP53—Barrett's esophagus	2.66e-05	0.0033	CbGpPWpGaD
Omeprazole—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	2.64e-05	0.000665	CcSEcCtD
Omeprazole—Epistaxis—Esomeprazole—Barrett's esophagus	2.64e-05	0.000663	CcSEcCtD
Omeprazole—Sinusitis—Esomeprazole—Barrett's esophagus	2.62e-05	0.00066	CcSEcCtD
Omeprazole—Agranulocytosis—Esomeprazole—Barrett's esophagus	2.61e-05	0.000656	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	2.6e-05	0.00322	CbGpPWpGaD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	2.58e-05	0.0032	CbGpPWpGaD
Omeprazole—Bradycardia—Esomeprazole—Barrett's esophagus	2.56e-05	0.000643	CcSEcCtD
Omeprazole—Rhinitis—Esomeprazole—Barrett's esophagus	2.52e-05	0.000633	CcSEcCtD
Omeprazole—Hepatitis—Esomeprazole—Barrett's esophagus	2.51e-05	0.000631	CcSEcCtD
Omeprazole—Hallucination—Esomeprazole—Barrett's esophagus	2.5e-05	0.000628	CcSEcCtD
Omeprazole—Hypoaesthesia—Esomeprazole—Barrett's esophagus	2.5e-05	0.000628	CcSEcCtD
Omeprazole—Pharyngitis—Esomeprazole—Barrett's esophagus	2.49e-05	0.000627	CcSEcCtD
Omeprazole—Urinary tract disorder—Esomeprazole—Barrett's esophagus	2.48e-05	0.000623	CcSEcCtD
Omeprazole—Oedema peripheral—Esomeprazole—Barrett's esophagus	2.47e-05	0.000622	CcSEcCtD
Omeprazole—Connective tissue disorder—Esomeprazole—Barrett's esophagus	2.47e-05	0.00062	CcSEcCtD
Omeprazole—Urethral disorder—Esomeprazole—Barrett's esophagus	2.46e-05	0.000619	CcSEcCtD
Omeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	2.46e-05	0.00305	CbGpPWpGaD
Omeprazole—CYP1B1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	2.43e-05	0.00301	CbGpPWpGaD
Omeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	2.43e-05	0.00301	CbGpPWpGaD
Omeprazole—Visual impairment—Esomeprazole—Barrett's esophagus	2.42e-05	0.000608	CcSEcCtD
Omeprazole—ABCC3—NRF2 pathway—HGF—Barrett's esophagus	2.41e-05	0.00299	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	2.41e-05	0.00299	CbGpPWpGaD
Omeprazole—Erythema multiforme—Esomeprazole—Barrett's esophagus	2.37e-05	0.000597	CcSEcCtD
Omeprazole—Eye disorder—Esomeprazole—Barrett's esophagus	2.35e-05	0.00059	CcSEcCtD
Omeprazole—Tinnitus—Esomeprazole—Barrett's esophagus	2.34e-05	0.000589	CcSEcCtD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.34e-05	0.0029	CbGpPWpGaD
Omeprazole—Flushing—Esomeprazole—Barrett's esophagus	2.33e-05	0.000586	CcSEcCtD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	2.27e-05	0.00281	CbGpPWpGaD
Omeprazole—Immune system disorder—Esomeprazole—Barrett's esophagus	2.27e-05	0.00057	CcSEcCtD
Omeprazole—Mediastinal disorder—Esomeprazole—Barrett's esophagus	2.26e-05	0.000569	CcSEcCtD
Omeprazole—Chills—Esomeprazole—Barrett's esophagus	2.25e-05	0.000566	CcSEcCtD
Omeprazole—Alopecia—Esomeprazole—Barrett's esophagus	2.22e-05	0.000558	CcSEcCtD
Omeprazole—Mental disorder—Esomeprazole—Barrett's esophagus	2.2e-05	0.000553	CcSEcCtD
Omeprazole—Malnutrition—Esomeprazole—Barrett's esophagus	2.18e-05	0.00055	CcSEcCtD
Omeprazole—Flatulence—Esomeprazole—Barrett's esophagus	2.15e-05	0.000542	CcSEcCtD
Omeprazole—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	2.15e-05	0.00267	CbGpPWpGaD
Omeprazole—Tension—Esomeprazole—Barrett's esophagus	2.14e-05	0.000539	CcSEcCtD
Omeprazole—Dysgeusia—Esomeprazole—Barrett's esophagus	2.14e-05	0.000538	CcSEcCtD
Omeprazole—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.12e-05	0.00263	CbGpPWpGaD
Omeprazole—Nervousness—Esomeprazole—Barrett's esophagus	2.12e-05	0.000534	CcSEcCtD
Omeprazole—Back pain—Esomeprazole—Barrett's esophagus	2.11e-05	0.000532	CcSEcCtD
Omeprazole—Muscle spasms—Esomeprazole—Barrett's esophagus	2.1e-05	0.000528	CcSEcCtD
Omeprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	2.07e-05	0.00257	CbGpPWpGaD
Omeprazole—Vision blurred—Esomeprazole—Barrett's esophagus	2.06e-05	0.000518	CcSEcCtD
Omeprazole—Tremor—Esomeprazole—Barrett's esophagus	2.05e-05	0.000515	CcSEcCtD
Omeprazole—Ill-defined disorder—Esomeprazole—Barrett's esophagus	2.03e-05	0.00051	CcSEcCtD
Omeprazole—Anaemia—Esomeprazole—Barrett's esophagus	2.02e-05	0.000508	CcSEcCtD
Omeprazole—Agitation—Esomeprazole—Barrett's esophagus	2.01e-05	0.000505	CcSEcCtD
Omeprazole—Angioedema—Esomeprazole—Barrett's esophagus	2e-05	0.000502	CcSEcCtD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	1.99e-05	0.00247	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	1.98e-05	0.00246	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	1.97e-05	0.00245	CbGpPWpGaD
Omeprazole—Malaise—Esomeprazole—Barrett's esophagus	1.97e-05	0.000496	CcSEcCtD
Omeprazole—Vertigo—Esomeprazole—Barrett's esophagus	1.96e-05	0.000494	CcSEcCtD
Omeprazole—Leukopenia—Esomeprazole—Barrett's esophagus	1.96e-05	0.000492	CcSEcCtD
Omeprazole—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.95e-05	0.00241	CbGpPWpGaD
Omeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	1.93e-05	0.0024	CbGpPWpGaD
Omeprazole—Palpitations—Esomeprazole—Barrett's esophagus	1.93e-05	0.000486	CcSEcCtD
Omeprazole—Cough—Esomeprazole—Barrett's esophagus	1.91e-05	0.00048	CcSEcCtD
Omeprazole—Hypertension—Esomeprazole—Barrett's esophagus	1.89e-05	0.000474	CcSEcCtD
Omeprazole—Myalgia—Esomeprazole—Barrett's esophagus	1.86e-05	0.000468	CcSEcCtD
Omeprazole—Arthralgia—Esomeprazole—Barrett's esophagus	1.86e-05	0.000468	CcSEcCtD
Omeprazole—Chest pain—Esomeprazole—Barrett's esophagus	1.86e-05	0.000468	CcSEcCtD
Omeprazole—Anxiety—Esomeprazole—Barrett's esophagus	1.85e-05	0.000466	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	1.85e-05	0.000465	CcSEcCtD
Omeprazole—Discomfort—Esomeprazole—Barrett's esophagus	1.84e-05	0.000462	CcSEcCtD
Omeprazole—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	1.84e-05	0.00228	CbGpPWpGaD
Omeprazole—Dry mouth—Esomeprazole—Barrett's esophagus	1.82e-05	0.000458	CcSEcCtD
Omeprazole—Confusional state—Esomeprazole—Barrett's esophagus	1.8e-05	0.000452	CcSEcCtD
Omeprazole—Anaphylactic shock—Esomeprazole—Barrett's esophagus	1.78e-05	0.000449	CcSEcCtD
Omeprazole—Infection—Esomeprazole—Barrett's esophagus	1.77e-05	0.000446	CcSEcCtD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.77e-05	0.0022	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	1.76e-05	0.00218	CbGpPWpGaD
Omeprazole—Shock—Esomeprazole—Barrett's esophagus	1.75e-05	0.000441	CcSEcCtD
Omeprazole—Nervous system disorder—Esomeprazole—Barrett's esophagus	1.75e-05	0.00044	CcSEcCtD
Omeprazole—Thrombocytopenia—Esomeprazole—Barrett's esophagus	1.75e-05	0.000439	CcSEcCtD
Omeprazole—Tachycardia—Esomeprazole—Barrett's esophagus	1.74e-05	0.000438	CcSEcCtD
Omeprazole—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.74e-05	0.00215	CbGpPWpGaD
Omeprazole—Skin disorder—Esomeprazole—Barrett's esophagus	1.73e-05	0.000436	CcSEcCtD
Omeprazole—Hyperhidrosis—Esomeprazole—Barrett's esophagus	1.72e-05	0.000434	CcSEcCtD
Omeprazole—Anorexia—Esomeprazole—Barrett's esophagus	1.7e-05	0.000428	CcSEcCtD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	1.65e-05	0.00205	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	1.65e-05	0.00204	CbGpPWpGaD
Omeprazole—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	1.62e-05	0.000409	CcSEcCtD
Omeprazole—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	1.62e-05	0.00201	CbGpPWpGaD
Omeprazole—Insomnia—Esomeprazole—Barrett's esophagus	1.61e-05	0.000406	CcSEcCtD
Omeprazole—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	1.61e-05	0.00199	CbGpPWpGaD
Omeprazole—Paraesthesia—Esomeprazole—Barrett's esophagus	1.6e-05	0.000403	CcSEcCtD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	1.6e-05	0.00198	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.6e-05	0.00198	CbGpPWpGaD
Omeprazole—Dyspnoea—Esomeprazole—Barrett's esophagus	1.59e-05	0.0004	CcSEcCtD
Omeprazole—Somnolence—Esomeprazole—Barrett's esophagus	1.59e-05	0.000399	CcSEcCtD
Omeprazole—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.58e-05	0.00196	CbGpPWpGaD
Omeprazole—Dyspepsia—Esomeprazole—Barrett's esophagus	1.57e-05	0.000395	CcSEcCtD
Omeprazole—Decreased appetite—Esomeprazole—Barrett's esophagus	1.55e-05	0.00039	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	1.54e-05	0.000387	CcSEcCtD
Omeprazole—Fatigue—Esomeprazole—Barrett's esophagus	1.54e-05	0.000387	CcSEcCtD
Omeprazole—Constipation—Esomeprazole—Barrett's esophagus	1.52e-05	0.000384	CcSEcCtD
Omeprazole—Pain—Esomeprazole—Barrett's esophagus	1.52e-05	0.000384	CcSEcCtD
Omeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.5e-05	0.00186	CbGpPWpGaD
Omeprazole—Feeling abnormal—Esomeprazole—Barrett's esophagus	1.47e-05	0.00037	CcSEcCtD
Omeprazole—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	1.46e-05	0.000367	CcSEcCtD
Omeprazole—Urticaria—Esomeprazole—Barrett's esophagus	1.42e-05	0.000356	CcSEcCtD
Omeprazole—Abdominal pain—Esomeprazole—Barrett's esophagus	1.41e-05	0.000355	CcSEcCtD
Omeprazole—Body temperature increased—Esomeprazole—Barrett's esophagus	1.41e-05	0.000355	CcSEcCtD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.37e-05	0.0017	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	1.37e-05	0.0017	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	1.37e-05	0.00169	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.35e-05	0.00168	CbGpPWpGaD
Omeprazole—Hypersensitivity—Esomeprazole—Barrett's esophagus	1.31e-05	0.00033	CcSEcCtD
Omeprazole—Asthenia—Esomeprazole—Barrett's esophagus	1.28e-05	0.000322	CcSEcCtD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	1.27e-05	0.00158	CbGpPWpGaD
Omeprazole—Pruritus—Esomeprazole—Barrett's esophagus	1.26e-05	0.000317	CcSEcCtD
Omeprazole—CYP11A1—Metabolism—PTGES—Barrett's esophagus	1.24e-05	0.00153	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.23e-05	0.00152	CbGpPWpGaD
Omeprazole—Diarrhoea—Esomeprazole—Barrett's esophagus	1.22e-05	0.000307	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.21e-05	0.00151	CbGpPWpGaD
Omeprazole—Dizziness—Esomeprazole—Barrett's esophagus	1.18e-05	0.000297	CcSEcCtD
Omeprazole—Vomiting—Esomeprazole—Barrett's esophagus	1.13e-05	0.000285	CcSEcCtD
Omeprazole—Rash—Esomeprazole—Barrett's esophagus	1.12e-05	0.000283	CcSEcCtD
Omeprazole—Dermatitis—Esomeprazole—Barrett's esophagus	1.12e-05	0.000283	CcSEcCtD
Omeprazole—Headache—Esomeprazole—Barrett's esophagus	1.12e-05	0.000281	CcSEcCtD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.12e-05	0.00139	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.09e-05	0.00135	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGES—Barrett's esophagus	1.07e-05	0.00133	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	1.06e-05	0.00131	CbGpPWpGaD
Omeprazole—Nausea—Esomeprazole—Barrett's esophagus	1.06e-05	0.000266	CcSEcCtD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	1.05e-05	0.0013	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.04e-05	0.0013	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGES—Barrett's esophagus	1.04e-05	0.00129	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	1.02e-05	0.00127	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	1.01e-05	0.00126	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1e-05	0.00124	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	9.91e-06	0.00123	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.55e-06	0.00118	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP26A1—Barrett's esophagus	9.37e-06	0.00116	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.93e-06	0.00111	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	8.37e-06	0.00104	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.14e-06	0.00101	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP26A1—Barrett's esophagus	8.11e-06	0.00101	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	8.04e-06	0.000997	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP26A1—Barrett's esophagus	7.89e-06	0.000978	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGES—Barrett's esophagus	7.89e-06	0.000978	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.38e-06	0.000916	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGES—Barrett's esophagus	7.18e-06	0.00089	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.95e-06	0.000862	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.92e-06	0.000859	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	6.83e-06	0.000847	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—SLC9A1—Barrett's esophagus	6.75e-06	0.000838	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP26A1—Barrett's esophagus	5.98e-06	0.000741	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SLC9A1—Barrett's esophagus	5.84e-06	0.000725	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.83e-06	0.000723	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—SLC9A1—Barrett's esophagus	5.69e-06	0.000705	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.45e-06	0.000675	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	5.44e-06	0.000674	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.39e-06	0.000669	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGES—Barrett's esophagus	4.86e-06	0.000602	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.58e-06	0.000569	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.53e-06	0.000561	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGES—Barrett's esophagus	4.45e-06	0.000552	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.42e-06	0.000548	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SLC9A1—Barrett's esophagus	4.31e-06	0.000534	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.09e-06	0.000508	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.97e-06	0.000493	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	3.92e-06	0.000486	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.88e-06	0.000481	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	3.68e-06	0.000457	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.66e-06	0.000453	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.62e-06	0.000449	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.47e-06	0.000431	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	3.37e-06	0.000419	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGES—Barrett's esophagus	3.1e-06	0.000384	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PPARG—Barrett's esophagus	3.08e-06	0.000382	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	3.01e-06	0.000374	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.94e-06	0.000365	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.77e-06	0.000344	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.75e-06	0.000341	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.72e-06	0.000337	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—Barrett's esophagus	2.67e-06	0.000331	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.65e-06	0.000329	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—Barrett's esophagus	2.6e-06	0.000322	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.49e-06	0.000309	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.44e-06	0.000302	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	2.43e-06	0.000302	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—Barrett's esophagus	2.43e-06	0.000301	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.39e-06	0.000296	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.35e-06	0.000291	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.23e-06	0.000276	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.17e-06	0.000269	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.14e-06	0.000265	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.12e-06	0.000263	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—Barrett's esophagus	2.1e-06	0.00026	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—Barrett's esophagus	2.04e-06	0.000253	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.03e-06	0.000252	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2e-06	0.000248	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.98e-06	0.000246	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—Barrett's esophagus	1.97e-06	0.000244	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.96e-06	0.000243	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.81e-06	0.000225	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.79e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.75e-06	0.000217	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.73e-06	0.000215	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.69e-06	0.00021	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.6e-06	0.000198	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—Barrett's esophagus	1.55e-06	0.000192	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.41e-06	0.000175	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.36e-06	0.000169	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.31e-06	0.000162	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.21e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.11e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—Barrett's esophagus	9.91e-07	0.000123	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—Barrett's esophagus	9.67e-07	0.00012	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	9.53e-07	0.000118	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—Barrett's esophagus	9.12e-07	0.000113	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—Barrett's esophagus	9.04e-07	0.000112	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	8.74e-07	0.000108	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	7.8e-07	9.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—Barrett's esophagus	7.72e-07	9.58e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—Barrett's esophagus	7.61e-07	9.44e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	7.17e-07	8.89e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	7.11e-07	8.82e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	6.08e-07	7.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.96e-07	7.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.69e-07	5.82e-05	CbGpPWpGaD
